5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK
Longeveron Inc. (NASDAQ: LGVN) announced in July 2024 that the FDA granted Fast Track designation for its cellular therapy, Lomecel-B™, aimed at treating mild Alzheimer’s Disease, accelerating its clinical development.…